| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.18 | 0.003 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |